Literature DB >> 21896314

Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers.

Anna Nogalska1, Carla D'Agostino, W King Engel, Valerie Askanas.   

Abstract

s-IBM is the most common muscle disease of older persons. Its muscle fiber molecular phenotype has close similarities to Alzheimer disease (AD) brain, including intra-muscle-fiber accumulations of (a) Aβ42 and its oligomers, and (b) large, squiggly or linear, clusters of paired-helical filaments (PHFs) that are immunoreactive with various antibodies directed against several epitopes of phosphorylated tau (p-tau), and thereby strongly resembling neurofibrillary tangles of AD brain. In AD brain, conformational changes of tau, including its modifications detectable with specific antibodies TG3 (recognizing phosphorylated-Thr231), and Alz50 and MC1 (both recognizing amino acids 5-15 and 312-322) are considered early and important modifications leading to tau's abnormal folding and assembly into PHFs. We have now identified conformationally modified tau in 14 s-IBM muscle biopsies by (a) light-and electron-microscopic immunohistochemistry, (b) immunoblots, and (c) dot-immunoblots, using TG3, Alz50 and MC1 antibodies. Our double-immunolabeling on the light- and electron-microscopic levels, which combined an antibody against p62 that recognizes s-IBM clusters of PHFs, revealed that TG3 immunodecorated, abundantly and exclusively, all p62 immunopositive clusters, while Alz50 labeling was less abundant, and MC1 was mainly diffusely immunoreactive. Interestingly, in the very atrophic degenerating fibers, TG3 co-localized with PHF-1 antibody that recognizes tau phosphorylated at Ser396/404, which is considered a later change in the formation of PHFs; however, most of TG3-positive inclusions in non-atrophic fibers were immunonegative with PHF-1. None of the 12 normal- and disease-control muscle biopsies contained conformational or PHF-1 immunoreactive tau. This first demonstration of conformational tau in s-IBM, because of its abundance in non-atrophic muscle fibers, suggests that it might play an early role in s-IBM PHFs formation and thus be pathogenically important.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896314     DOI: 10.1016/j.neulet.2011.08.042

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Formation of gelsolin amyloid fibrils in the rough endoplasmic reticulum of skeletal muscle in the gelsolin mouse model of inclusion body myositis: comparative analysis to human sporadic inclusion body myositis.

Authors:  Sergei I Bannykh; William E Balch; Jeffery W Kelly; Lesley J Page; G Diane Shelton
Journal:  Ultrastruct Pathol       Date:  2013-10       Impact factor: 1.094

Review 2.  P62/SQSTM1 at the interface of aging, autophagy, and disease.

Authors:  Alessandro Bitto; Chad A Lerner; Timothy Nacarelli; Elizabeth Crowe; Claudio Torres; Christian Sell
Journal:  Age (Dordr)       Date:  2014-02-21

3.  De novo prion aggregates trigger autophagy in skeletal muscle.

Authors:  Shivanjali Joshi-Barr; Cyrus Bett; Wei-Chieh Chiang; Margarita Trejo; Hans H Goebel; Beata Sikorska; Pawel Liberski; Alex Raeber; Jonathan H Lin; Eliezer Masliah; Christina J Sigurdson
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

4.  Inclusion body myositis associated with Sjögren's syndrome.

Authors:  Maria Misterska-Skóra; Agata Sebastian; Piotr Dzięgiel; Maciej Sebastian; Piotr Wiland
Journal:  Rheumatol Int       Date:  2012-12-12       Impact factor: 2.631

5.  Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis.

Authors:  Leonardo Valente de Camargo; Mary Souza de Carvalho; Samuel Katsuyuki Shinjo; Acary Souza Bulle de Oliveira; Edmar Zanoteli
Journal:  Biomed Res Int       Date:  2018-01-29       Impact factor: 3.411

6.  Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies.

Authors:  Therése Klingstedt; Cristiane Blechschmidt; Anna Nogalska; Stefan Prokop; Bo Häggqvist; Olof Danielsson; W King Engel; Valerie Askanas; Frank L Heppner; K Peter R Nilsson
Journal:  Chembiochem       Date:  2013-02-28       Impact factor: 3.164

7.  Altered Blood Biomarker Profiles in Athletes with a History of Repetitive Head Impacts.

Authors:  Alex P Di Battista; Shawn G Rhind; Doug Richards; Nathan Churchill; Andrew J Baker; Michael G Hutchison
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.